Advantages and disadvantages of disulfiram coadministered with popular addictive substances

Disulfiram Treatment Normalizes Body Weight in Obese Mice

(2020) Michel Bernier et al.   Cell Metabolism

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

(2020) Betsy J. Barnes et al.   JOURNAL OF EXPERIMENTAL MEDICINE

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

(2020) Jun Jacob Hu et al.   NATURE IMMUNOLOGY

Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats

(2020) Ziad Omran et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

The Positive and Negative Outcome of Morphine and Disulfiram Subacute Co-Administration in Rats in the Absence of Ethanol Challenge

(2020) Karolina Frączek et al.   Pharmaceutics

Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis

(2019) Karleigh A. Hamblin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Disulfiram attenuates morphine or methadone withdrawal syndrome in mice

(2018) Anna de Cordé et al.   BEHAVIOURAL PHARMACOLOGY

Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review

(2018) Simona Guerzoni et al.   PHARMACOLOGICAL RESEARCH

Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks

(2018) Sven Reinhardt et al.   Scientific Reports

Antibacterial activity of disulfiram and its metabolites

(2018) Keely R Frazier et al.   JOURNAL OF APPLIED MICROBIOLOGY

Disulfiram Induced Psychosis

(2017) Satyakam Mohapatra et al.   Clinical Psychopharmacology and Neuroscience

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

(2016) X. Lun et al.   CLINICAL CANCER RESEARCH

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment

(2013) Richard S. Schottenfeld et al.   DRUG AND ALCOHOL DEPENDENCE

Opioid induced nausea and vomiting

(2013) Howard S. Smith et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Disulfiram-Induced Combined Irreversible Anterior Ischemic Optic Neuropathy and Reversible Peripheral Neuropathy: A Prospective Case Report and Review of the Literature

(2013) Ranganath R. Kulkarni et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Inhibition of NF- B Signaling Ablates the Invasive Phenotype of Glioblastoma

(2013) M.-A. Westhoff et al.   MOLECULAR CANCER RESEARCH

Medical Consequences of Marijuana Use: A Review of Current Literature

(2013) Adam J. Gordon et al.   Current Psychiatry Reports

Antitubercular Activity of Disulfiram, an Antialcoholism Drug, against Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates

(2012) Yasuhiro Horita et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Impact of Disulfiram Treatment on the Reinforcing Effects of Cocaine: A Randomized Clinical Trial

(2012) Colin N. Haile et al.   PLoS One

Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats

(2011) Tienian Zhu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior

(2011) Ream Al-Hasani et al.   ANESTHESIOLOGY

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

(2011) N C Yip et al.   BRITISH JOURNAL OF CANCER

The ABCC4 gene is a promising target for pancreatic cancer therapy

(2011) Zhuo Zhang et al.   GENE

Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase

(2010) Jason P Schroeder et al.   NEUROPSYCHOPHARMACOLOGY

Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse

(2009) M. Gaval-Cruz et al.   MOLECULAR INTERVENTIONS

Opioids and the control of respiration

(2008) K.T.S. Pattinson   BRITISH JOURNAL OF ANAESTHESIA

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence

(2007) Helen M. Pettinati et al.   ADDICTIVE BEHAVIORS